BioSpace News Archive

Capricor Therapeutics, Inc. announced today that the first two patients have been dosed in its Phase 2 study evaluating intravenous infusion of CAP-1002

A team from the Institut national de la recherche scientifique has demonstrated the effectiveness of an inexpensive molecule to fight antibiotic-resistant strains of the bacteria responsible for gonorrhea and meningococcal meningitis.

Vivacelle Bio, Inc. today announces the Department of Defense awarded $5.3 million (USD) dollars for the clinical trial of VBI-S, an intravenously injected fluid based upon Vivacelle Bio’s phospholipid nanoparticle technology for the treatment of septic shock due to various pathogens including COVID-19, other viruses and/or bacteria

Vvital Biomed (“Vvital”), a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), a leading Israel- and Singapore-based investment group focused on high-growth medical and agrifood technologies, announced that three world-renowned cardiologists have recently joined the advisory board of Vvital, strengthening the company’s capabilities to build its solution for mitral and tricuspid valve repair.

Heska Corporation (NASDAQ: HSKA - News; “Heska” or the “Company”), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska’s President & Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on Tuesday, December 1, 2020.

AlmirallShare, the open innovation platform of Almirall, S.A., announces two new collaborations with the University of South Australia and the Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau to find new pathways for the treatment of skin cancer and atopic dermatitis.

Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced that Craig Thompson, President and Chief Executive Officer, will present at the Piper Sandler 32nd Annual Healthcare Conference and participate in one-on-one meetings with investors

Dario’s top-rated digital diabetes tools and coaching will be available to eligible employees and their dependents starting January 1, 2021

QYNAPSE Inc. a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, is pleased to sponsor the 106th Radiology Society of North America (RSNA) Annual Meeting – the most important week in radiology.

Ibex Medical Analytics, a pioneer in artificial intelligence (AI)-based cancer diagnostics, today announced the addition of David Shulkin, M.D., and Joe Robinson to its advisory board.